Indication
Ischemic Cardiomyopathy
4 clinical trials
4 products
Clinical trial
Randomized Evaluation and Verification of Ventricular Enhancement: The REVIVE-HF StudyStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
GDMTClinical trial
Effect of Alpha-lipoic Acid on Inflammatory and Cardiac Fibrosis Markers in Diabetic Patients With Ischemic CardiomyopathyStatus: Completed, Estimated PCD: 2024-01-31
Product
Alpha Lipoic AcidClinical trial
Impact of PREVENTIVE Substrate Catheter Ablation on Implantable cardioVerter-defibrillaTor Interventions in Patients With Ischaemic Cardiomyopathy and Infarct-related Coronary Chronic Total OcclusionStatus: Completed, Estimated PCD: 2024-01-04
Product
Optimal medical treatmentClinical trial
Venous Ethanol for Ischemic Left Ventricular TachycardiaStatus: Recruiting, Estimated PCD: 2027-12-12
Product
Venous ethanol